BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 46 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $9,376,000 | -3.0% | 8,667,000 | 0.0% | 0.00% | -25.0% |
| Q3 2017 | $9,669,000 | +2.4% | 8,667,000 | +1.8% | 0.00% | +33.3% |
| Q2 2017 | $9,438,000 | -1.9% | 8,517,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $9,619,000 | +1.0% | 8,517,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $9,523,000 | -6.8% | 8,517,000 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $10,215,000 | +8.0% | 8,517,000 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $9,459,000 | -4.1% | 8,517,000 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $9,864,000 | -9.8% | 8,517,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $10,934,000 | -32.4% | 8,517,000 | -32.0% | 0.00% | -42.9% |
| Q3 2015 | $16,170,000 | -16.2% | 12,517,000 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $19,292,000 | +3.6% | 12,517,000 | 0.0% | 0.01% | +14.3% |
| Q1 2015 | $18,627,000 | +26.6% | 12,517,000 | 0.0% | 0.01% | +16.7% |
| Q4 2014 | $14,715,000 | +7.9% | 12,517,000 | -2.8% | 0.01% | +20.0% |
| Q3 2014 | $13,637,000 | +28.6% | 12,880,000 | +25.7% | 0.01% | +25.0% |
| Q2 2014 | $10,602,000 | +4.6% | 10,250,000 | +10.8% | 0.00% | 0.0% |
| Q1 2014 | $10,135,000 | +3.4% | 9,250,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $9,799,000 | – | 9,250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ferox Capital Management LP | 5,000,000 | $5,356,000 | 2.91% |
| Lombard Odier Asset Management (Europe) Ltd | 31,900,000 | $34,087,000 | 2.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 15,970,000 | $16,929,000 | 1.92% |
| MACKAY SHIELDS LLC | 24,283,000 | $25,802,000 | 1.34% |
| Verition Fund Management LLC | 7,982,000 | $8,491,000 | 1.20% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 62,750,000 | $66,638,000 | 1.03% |
| OAKTREE CAPITAL MANAGEMENT LP | 34,510,000 | $37,002,000 | 0.61% |
| Jabre Capital Partners S.A. | 3,500,000 | $3,722,000 | 0.32% |
| Calamos Wealth Management LLC | 656,000 | $695,000 | 0.20% |
| Baker Brothers Advisors | 12,500,000 | $13,203,000 | 0.17% |